Skip to main content

Table 1 Patients characteristics

From: Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)

 

Group A

Group B

No. of patients*

76

77

Median age (±S.D.) (years)*

35.9 (6.2)

37.1 (6.5)

Sexual bahaviour (%)

  

  Only 1 partner*

50 (65.8)

52 (67.5)

  2 or more partners*

26 (34.2)

25 (32.5)

Contraceptive method (%)

  

  No contraceptive**

28 (36.7)

31 (40.3)

  Condom*

9 (11.8)

9 (11.7)

  Coitus interruptus**

39 (51.3)

37 (48.1)

Urinary symptoms (%)

  

  Burning*

65 (85.6)

65 (84.4)

  Tenesmus*

24 (31.6)

26 (33.8)

  Pain**

40 (52.6)

34 (44.2)

  Urgency**

40 (52.6)

32 (41.6)

  Frequency**

46 (60.5)

55 (71.4)

Beginning of CBP (months)*

15.9

17.4

  1. *not-statistically significant difference between Group A and B.
  2. **statistically significant difference between Group A and B.